BioMark Capital

Life sciences investment firm focused on innovative biotechnology and healthcare companies. Invests across therapeutic, diagnostic, and healthcare technology sectors with emphasis on platform technologies.

Location
San Francisco, USA
Founded
2008
AUM
$500M+
Investment Range
$5M - $50M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth